Association of HLA-DQA1*05 with the Presence of Interstitial Lung Disease Independent of Autoantibody Status in Caucasian Patients with Polymyositis and Dermatomyositis

被引：0
|
作者：
Schiffenbauer, Adam [1 ]
Faghihi-Kashani, Sara [2 ]
O'Hanlon, Terrance P. [1 ]
Flegel, Willy [3 ]
Adams, Sharon [3 ]
Targoff, Ira N. [4 ]
Oddis, Chester V. [5 ,6 ]
Aggarwal, Rohit [7 ,8 ]
Rider, Lisa G. [1 ]
Ytterberg, Steven R. [9 ]
Christopher-Stine, Lisa [10 ]
Danoff, Sonye K. [11 ]
Dellaripa, Paul F. [12 ,13 ]
Shamim, Ejaz [14 ]
Mammen, Andrew [15 ]
Miller, Frederick W. [16 ]
机构：
[1] NIEHS, Environm Autoimmun Grp, NIH, Bethesda, MD USA
[2] Natl Inst Environm Hlth, Environm Autoimmun Grp, Bethesda, MD USA
[3] NIH, Dept Transfus Med, Bethesda, MD 20892 USA
[4] Univ Oklahoma, Oklahoma Med Res Fdn, Hlth Sci Ctr, VA Med Ctr, Oklahoma City, OK USA
[5] Univ Pittsburgh, Med Ctr, Rheumatol Clin Immunol, Pittsburgh, PA USA
[6] Univ Pittsburgh, Rheum Clin Immunol, Pittsburgh, PA USA
[7] Ist Giannina Gaslini, PRINTO, Reumatol, Pediat 2, Genoa, Italy
[8] Univ Pittsburgh, Med Ctr, Dept Med Rheumatol, Pittsburgh, PA USA
[9] Mayo Clin, Rheumatol, Rochester, MN USA
[10] Johns Hopkins Univ, Sch Med, Med, Baltimore, MD USA
[11] Johns Hopkins Univ, Med Pulm, Baltimore, MD USA
[12] Brigham & Womens Hosp, Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA
[13] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA
[14] Kaiser Permanente, Midatlantic Permanente Res Inst, Dept Neurol 9, Rockville, MD USA
[15] NIAMSD, Muscle Dis Unit, NIH, Bethesda, MD 20892 USA
[16] NIH, Clin Res Branch, Environm Autoimmun Grp, Bldg 10, Bethesda, MD 20892 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2136
引用
收藏
页数：3
相关论文
共 50 条
  • [21] HLA-DQA1*05 Allele Carriage and Anti-TNF Therapy Persistence in Inflammatory Bowel Disease
    Doherty, J.
    Ryan, A.
    Quinn, E.
    Dolan, J.
    Corcoran, R.
    Hara, F. O'
    Bailey, Y.
    McNamara, D.
    Doherty, G.
    Kevans, D.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 734 - 734
  • [22] HLA-DQA1*05 Allele Carriage and Anti-TNF Therapy Persistence in Inflammatory Bowel Disease
    Doherty, Jayne
    Ryan, Anthony W.
    Quinn, Emma
    Conroy, Judith
    Dolan, Jackie
    Corcoran, Roisin
    Hara, Fintan O.
    Cullen, Garret
    Sheridan, Juliette
    Bailey, Yvonne
    Dunne, Cara
    Hartery, Karen
    Mcnamara, Deirdre
    Doherty, Glen A.
    Kevans, David
    INFLAMMATORY BOWEL DISEASES, 2024,
  • [23] Clinical Heterogeneity of Interstitial Lung Disease in Polymyositis and Dermatomyositis Patients With or Without Specific Autoantibodies
    Chen, Fang
    Li, Shanshan
    Wang, Tao
    Shi, Jingli
    Wang, Guochun
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2018, 355 (01): : 48 - 53
  • [24] KL-6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis
    Fathi, M.
    Helmers, S. Barbasso
    Lundberg, I. E.
    JOURNAL OF INTERNAL MEDICINE, 2012, 271 (06) : 589 - 597
  • [25] HLA-DQA1*05 and upstream variants of PPARGC1B are associated with infliximab persistence in Japanese Crohn's disease patients
    Shimoda, Fumiko
    Naito, Takeo
    Kakuta, Yoichi
    Kawai, Yosuke
    Tokunaga, Katsushi
    NCBN Controls WGS Consortium, Michio
    Shimoyama, Yusuke
    Moroi, Rintaro
    Shiga, Hisashi
    Nagasaki, Masao
    Kinouchi, Yoshitaka
    Masamune, Atsushi
    Ishibashi-Ueda, Hatsue
    Tomita, Tsutomu
    Noguchi, Michio
    Takahashi, Ayako
    Goto, Yu-ichi
    Yoshida, Sumiko
    Hattori, Kotaro
    Matsumura, Ryo
    Iida, Aritoshi
    Maruoka, Yutaka
    Gatanaga, Hiroyuki
    Sugiyama, Masaya
    Suzuki, Satoshi
    Miyo, Kengo
    Matsubara, Yoichi
    Umezawa, Akihiro
    Hata, Kenichiro
    Kaname, Tadashi
    Ozaki, Kouichi
    Tokuda, Haruhiko
    Watanabe, Hiroshi
    Niida, Shumpei
    Noiri, Eisei
    Kitajima, Koji
    Omae, Yosuke
    Miyahara, Reiko
    Shimanuki, Hideyuki
    Kawai, Yosuke
    Tokunaga, Katsushi
    PHARMACOGENOMICS JOURNAL, 2023, 23 (06): : 141 - 148
  • [26] HLA-DQA1*05 and upstream variants of PPARGC1B are associated with infliximab persistence in Japanese Crohn’s disease patients
    Fumiko Shimoda
    Takeo Naito
    Yoichi Kakuta
    Yosuke Kawai
    Katsushi Tokunaga
    Yusuke Shimoyama
    Rintaro Moroi
    Hisashi Shiga
    Masao Nagasaki
    Yoshitaka Kinouchi
    Atsushi Masamune
    The Pharmacogenomics Journal, 2023, 23 : 141 - 148
  • [27] HLA-DQA1*05 and development of anti-drug antibodies in anti-TNF treated patients with inflammatory bowel disease
    Lopez-Blanco, Ruben
    Mendez-Lopez, Isabel-Maria
    Recio-Romero, Rafael
    Luque-Fernandez, Rosario
    Caballero-Gonzalez, Abelardo
    Torio-Ruiz, Alberto
    HLA, 2022, 99 (05) : 539 - 540
  • [28] ANTIBODY TO JO-1 IN POLYMYOSITIS DERMATOMYOSITIS - ASSOCIATION WITH INTERSTITIAL PULMONARY-DISEASE
    HOCHBERG, MC
    FELDMAN, D
    STEVENS, MB
    ARNETT, FC
    REICHLIN, M
    JOURNAL OF RHEUMATOLOGY, 1984, 11 (05) : 663 - 665
  • [29] HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease
    Sazonovs, Aleksejs
    Kennedy, Nicholas A.
    Moutsianas, Loukas
    Heap, Graham A.
    Rice, Daniel L.
    Reppell, Mark
    Bewshea, Claire M.
    Chanchlani, Neil
    Walker, Gareth J.
    Perry, Mandy H.
    McDonald, Timothy J.
    Lees, Charlie W.
    Cummings, J. R. Fraser
    Parkes, Miles
    Mansfield, John C.
    Irving, Peter M.
    Barrett, Jeffrey C.
    McGovern, Dermot
    Goodhand, James R.
    Anderson, Carl A.
    Ahmad, Tariq
    GASTROENTEROLOGY, 2020, 158 (01) : 189 - 199
  • [30] Proactive Therapeutic drug monitoring of Infliximab, but not HLA-DQA1*05, predicts clinical outcome in inflammatory bowel disease
    Alonso, I.
    Carrillo Palau, M.
    Vera, B.
    Vela, M.
    Morant, A.
    Ramos, L.
    Reygosa, C.
    Medina Chico, J. S.
    Barrios, Y.
    Franco, A.
    Gutierrez-Nicolas, F.
    Jimenez, A.
    Hernandez-Guerra, M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I597 - I597
12345